Letizia Gandolfi
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?
Journal: Case reports in hematology
Published: January 30, 2019
Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis.
Journal: Hematological oncology
Published: December 15, 2016
Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients.
Journal: The oncologist
Published: March 16, 2016
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results.
Journal: Blood cancer journal
Published: February 04, 2016
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study.
Journal: Haematologica
Published: December 26, 2015
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years.
Journal: Cancer medicine
Published: December 01, 2015
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 19, 2015
Vemurafenib mucosal side-effect.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 13, 2015
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.
Journal: Hematological oncology
Published: July 28, 2014
Last Updated: 09/26/2026